News
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...
6d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...
As millions of South Africans received COVID-19 vaccines, a shocking US report reveals that health officials were aware of ...
Federal health agencies were alerted in February 2021 to “large reports of myocarditis” in young people who received the Pfizer vaccine, but waited until late June to adjust the ...
The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk ...
The Senate Homeland Security Committee holds a hearing on federal health agencies failing to warn the public about the potential side effects of the COVID-19 vaccines. At a Permanent Subcommittee on ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
4d
Khaleej Times on MSNUS limits Covid boosters to over-65s or those at high riskThe FDA said it would rely on lab test results to approve boosters for people who are over 65, or over six months old with at ...
4d
Tribune Online on MSNIHVN calls for enhanced adverse events monitoring following immunisationThe Institute of Human Virology Nigeria (IHVN) has emphasized the need for governments and healthcare facilities to train ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results